Published January 10, 2026
| Version 1.0.0
Book chapter
Open
The Risks of Antibiotic Resistance
Description
This document contains the cover page, abstract, and the first chapter of the book titled "The Risks of Antibiotic Resistance: A Comprehensive Study on Microbial Mechanisms and Global Health Impact". The full version of the book is officially published and registered with ISBN: 978-1-291-86534-9. This preview is intended for academic display and indexing purposes. The complete work is available through Lulu Press.
Files
Chapter 1 of The Risks of Antibiotic Resistance.pdf
Files
(883.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:d40ee921276c4ce151dc340b2068e17e
|
883.0 kB | Preview Download |
Additional details
Identifiers
Related works
- Is part of
- Book chapter: 978-1-291-86534-9 (ISBN)
Dates
- Issued
-
2026-01-10Initial publication on Lulu Press.
References
- Davies, J., & Davies, D. (2010). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 74(3), 417–433. https://doi.org/10.1128/MMBR.00016-10 Walsh, C. (2000). Molecular mechanisms that confer antibacterial drug resistance. Nature, 406(6797), 775–781. https://doi.org/10.1038/35021219 Murray, C. J., Ikuta, K. S., Sharara, F., et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0 Andrews, J. M. (2001). Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy, 48(suppl_1), 5–16. https://doi.org/10.1093/jac/48.suppl_1.5 Blair, J. M., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. (2015). Molecular mechanisms of antibiotic resistance. Nature Reviews Microbiology, 13(1), 42–51. https://doi.org/10.1038/nrmicro3380 Munita, J. M., & Arias, C. A. (2016). Mechanisms of antibiotic resistance. Microbiology Spectrum, 4(2). https://doi.org/10.1128/microbiolspec.VMBF-0016-2015 Turnidge, J., & Paterson, D. L. (2007). Setting and revising antibacterial susceptibility breakpoints. Clinical Microbiology Reviews, 20(3), 391–408. https://doi.org/10.1128/CMR.00047-06 Silver, L. L. (2011). Challenges of antibacterial discovery. Clinical Microbiology Reviews, 24(1), 71–109. https://doi.org/10.1128/CMR.00030-10 Teillant, A., Gandra, S., Barter, D., Morgan, D. J., & Laxminarayan, R. (2015). Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. The Lancet Infectious Diseases, 15(12), 1429–1437. https://doi.org/10.1016/S1473-3099(15)00270-4 Laxminarayan, R., Duse, A., Wattal, C., et al. (2013). Antibiotic resistance—the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9 Friedman, N. D., Temkin, E., & Carmeli, Y. (2016). The negative impact of antibiotic resistance. Clinical Microbiology and Infection, 22(5), 416–422. https://doi.org/10.1016/j.cmi.2015.12.002 O'Neill, J. (2016). Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. Mediavilla, J. R., Chen, L., Mathema, B., & Kreiswirth, B. N. (2012). Global epidemiology of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Current Opinion in Microbiology, 15(5), 588–595. https://doi.org/10.1016/j.mib.2012.08.003 Rodloff, A., Bauer, T., Ewig, S., Kujath, P., & Müller, E. (2008). Susceptible, intermediate, and resistant - the intensity of antibiotic action. Deutsches Ärzteblatt International, 105(39), 657–662. https://doi.org/10.3238/arztebl.2008.0657